Three 200%+ Gainers from Today's Session

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. 

Here’s what moved the market today.

Markets 📈

Stocks ended Monday with mixed results. The Nasdaq and S&P 500 pulled back slightly, while the Russ2K rallied.

More "Safe" Gold is Needed to Meet Growing Demand (ad)

Gold is an effective way to protect portfolios from the forces of war and uncertainty.

But gold reserves have declined, along with a lack of new gold discoveries.

To make up for growing gold demand, more new mining projects and gold discoveries are needed - particularly in safe jurisdictions such as the U.S.

See why American gold should be on every investor's radar.

» Want an Ad-Free Experience? Upgrade Now! 

Market-Moving News 🔎 

🚀 Is the Stock Market Too Expensive?

The stock market has kicked off 2024 on a high note, with the S&P 500 leaping over the 5000 mark, marking a series of record highs. The Dow Jones isn't far behind, with its own collection of milestones.

This surge has reignited the age-old debate among investors: Are we flying too close to the sun? Are stocks overvalued, or is there still room to grow?

💹 Valuation Maze
Determining if a stock or the broader market is a bargain or overpriced isn't straightforward. It's a complex blend of metrics, economic climate, company health, and industry trends. Growth prospects play a significant role, with high expectations often leading to higher price tags.

🔍The P/E Lens
The price/earnings (P/E) ratio stands as Wall Street's go-to yardstick for sizing up stock valuations, balancing stock prices against corporate earnings. This ratio sheds light on what investors are willing to shell out for a slice of a company's earnings.

A stable price with climbing earnings tightens valuations, while a dip in earnings can leave stocks looking pricier even without a price hike.

📊 A Tale of Two Ratios
The P/E ratio can be framed in two ways: trailing, which leans on the past 12 months of earnings, and forward, which casts an eye on the earnings horizon. The S&P 500's current standing—a trailing multiple of 24.18 overshooting its 10-year average, and a forward multiple stepping over the 20-mark—signals a market that's treading above its historical comfort zone.

As 2024 unfolds, investors are left weighing whether these lofty heights signal a market in its prime or one teetering on the edge of overvaluation.

Millennium Intl [MGIH] $3.11 (+201.9%)
rallied after YC 1926 (BVI) Ltd disclosed ownership of 10 million shares of MGIH, equal to an 88.89% ownership stake in the company.

Beamr Imaging [BMR]$9.95 (+371.5%)
landed a deal with NVIDIA [NVDA] to accelerate the adoption of the latest video standard, AV1.

Renalytix [RNLX] $1.25 (+228.0%)
continued to rally on rumors suggesting the company achieved a positive draft coverage determination for its KidneyIntelX test.

AN2 Therapeutics [ANTX] $5.10 (74.5%)
paused Phase 3 enrollment in a Phase 2/3 trial of EBO-301 in certain lung diseases, pending further data review.

MedAvail [MDVL] $1.80 (40.5%)
pulled back after several days of gains that began after RedMile Group disclosed a 73.0% stake in the company last week.

Top Financial [TOP] $3.20 (40.6%)
plummeted after rallying 64.7% on Friday. There was no obvious company-specific news or other catalyst to explain the sudden move.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Text ELITESTOCKS to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.